QIAGEN N.V.(NYSE:QGEN) stock News

QGEN Latest News, Press Relases and Analysis

All

Press Releases

2 days ago - By: Chartmill

QIAGEN N.V. (NYSE:QGEN) Passes the Caviar Cruise Quality Investment Screen

9 hours ago - By: Zacks Investment Research - Mentions: ILMN PACB TXG

PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations

10 hours ago - By: Zacks Investment Research - Mentions: GSK NVS INCY

Will Positive Regulatory Updates Further Boost INCY Stock?

7 days ago - By: QIAGEN N.V.

QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast

18 days ago - By: Zacks Investment Research - Mentions: ILMN TMO MYGN

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

19 days ago - By: Zacks Investment Research - Mentions: DGX TMO

Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing

20 days ago - By: Zacks Investment Research - Mentions: TMO ILMN PACB

PacBio Enters Carrier Screening Market With PureTarget Expansion

20 days ago - By: Zacks Investment Research - Mentions: TMO HOLX QDEL

QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test

20 days ago - By: Zacks Investment Research - Mentions: DGX EXAS GH

DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute

a month ago - By: QIAGEN N.V.

QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio

a month ago - By: Zacks Investment Research - Mentions: HOLX BDX

Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds

2 months ago - By: Zacks Investment Research - Mentions: MASI PAHC NVST

QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise

2 months ago - By: QIAGEN N.V.

QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing

2 months ago - By: Zacks Investment Research - Mentions: HOLX BSX

The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?

2 months ago - By: Zacks Investment Research - Mentions: NVS INCY

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

2 months ago - By: Zacks Investment Research

Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention

3 months ago - By: Zacks Investment Research

Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say

3 months ago - By: Zacks Investment Research - Mentions: DTIL

Qiagen (QGEN) Matches Q2 Earnings Estimates

3 months ago - By: QIAGEN N.V.

QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability

3 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

3 months ago - By: Benzinga

A Look at Qiagen's Upcoming Earnings Report

3 months ago - By: QIAGEN N.V.

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

3 months ago - By: QIAGEN N.V.

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast

4 months ago - By: QIAGEN N.V..

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

4 months ago - By: Yahoo Finance - Mentions: INCY ILMN VRNA

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions

4 months ago - By: Zacks Investment Research

Here's Why Qiagen (QGEN) is a Strong Growth Stock

4 months ago - By: QIAGEN N.V.

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

4 months ago - By: Stocktwits - Mentions: INCY ILMN

Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism

4 months ago - By: Yahoo Finance - Mentions: GS INCY RY RY.CA ...

Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches

4 months ago - By: QIAGEN N.V. - Mentions: INCY

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

5 months ago - By: Zacks Investment Research - Mentions: INCY

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?

5 months ago - By: Zacks Investment Research - Mentions: COR PAHC HIMS

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances

5 months ago - By: Yahoo Finance - Mentions: VZ ASC

KeyBank adopts Personetics platform to enhance client engagement

5 months ago - By: QIAGEN N.V.

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

5 months ago - By: Foresight Diagnostics, Inc.

QIAGEN N.V. (QGEN) Stock News

QGEN Latest News, Press Relases and Analysis

QIAGEN N.V. (NYSE:QGEN) Passes the Caviar Cruise Quality Investment Screen

PacBio Aims to Expand Multiomic Capabilities Via Latest Innovations

Will Positive Regulatory Updates Further Boost INCY Stock?

QIAGEN N.V. to Release Results for Q3 2025 and Hold Webcast

Illumina to Join Pharma Partners for CDx Development on KRAS Biomarker

Quest Diagnostics Joins Forces With Epic to Improve Laboratory Testing

PacBio Enters Carrier Screening Market With PureTarget Expansion

QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test

DGX's Haystack Oncology Teams Up With Rutgers Cancer Institute

QIAGEN Secures European CE-IVDR Certification for Full QIAstat-Dx Portfolio

Hologic's 2025 Outlook Improves on Strong Q3, Easing Tariff Headwinds

QIAGEN Stock May Benefit From the US Clearance of QIAstat-Dx Rise

QIAGEN Gains U.S. Clearance of Higher-Throughput QIAstat-Dx Rise, Expanding Patient Access to Rapid Syndromic Testing

The Role of M&A in Hologic's Growth Story: Are More Deals in Sight?

INCY Stock Trading Close to Its 52-Week High: Buy, Sell or Hold?

Why Qiagen (QGEN) International Revenue Trends Deserve Your Attention

Qiagen (QGEN) Reports Q2 Earnings: What Key Metrics Have to Say

Qiagen (QGEN) Matches Q2 Earnings Estimates

QIAGEN exceeds outlook for Q2 2025 with solid growth and improved profitability

Earnings Scheduled For August 5, 2025

A Look at Qiagen's Upcoming Earnings Report

QIAGEN Expands NGS Portfolio with Launch of QIAseq xHYB Long Read Panels

QIAGEN N.V. to Release Results for Q2 2025 and Hold Webcast

QIAGEN Announces Election of Stephen Rusckowski as Chairman of Supervisory Board

Incyte (INCY) Teams Up with QIAGEN to Boost Blood Cancer Diagnostic Solutions

Here's Why Qiagen (QGEN) is a Strong Growth Stock

QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership

Retail Investors Flock To Incyte As Drug Data, Qiagen Deal Fuel Optimism

Incyte (INCY) Targets $1B Growth by 2029 with New Drug Launches

QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)

Qiagen (QGEN) Up 8.1% Since Last Earnings Report: Can It Continue?

QGEN Stock to Gain From Expanding Oncology Portfolio via New Alliances

KeyBank adopts Personetics platform to enhance client engagement

QIAGEN expands portfolio for minimal residual disease (MRD) testing in oncology with new strategic partnerships

Foresight Diagnostics and QIAGEN Announce Strategic Partnership to Advance Development of Companion Diagnostic Kits for Lymphoma